Primary |
Urinary Tract Infection |
37.7% |
Product Used For Unknown Indication |
29.2% |
Cystitis |
10.4% |
Osteoporosis |
3.8% |
Antibiotic Prophylaxis |
1.9% |
Prostatitis |
1.9% |
Renal Colic |
1.9% |
Urinary Tract Infection Pseudomonal |
1.9% |
Antiviral Prophylaxis |
0.9% |
Arrhythmia |
0.9% |
Atrial Fibrillation |
0.9% |
Bacteria Urine Identified |
0.9% |
Bacterial Infection |
0.9% |
Bacterial Test Positive |
0.9% |
Dysuria |
0.9% |
Gout |
0.9% |
Hypertension |
0.9% |
Ischaemic Cardiomyopathy |
0.9% |
Palpitations |
0.9% |
Prostatic Adenoma |
0.9% |
|
Pyrexia |
10.8% |
Pruritus |
8.1% |
Tubulointerstitial Nephritis |
8.1% |
Diarrhoea |
5.4% |
Hepatic Failure |
5.4% |
Left Ventricular Hypertrophy |
5.4% |
Oligohydramnios |
5.4% |
Pulmonary Fibrosis |
5.4% |
Rectal Haemorrhage |
5.4% |
Septic Shock |
5.4% |
Tenderness |
5.4% |
Thrombocytopenia |
5.4% |
Thrombotic Thrombocytopenic Purpura |
5.4% |
Acute Generalised Exanthematous Pustulosis |
2.7% |
Acute Respiratory Distress Syndrome |
2.7% |
Alanine Aminotransferase Increased |
2.7% |
Drug Exposure During Pregnancy |
2.7% |
Drug Hypersensitivity |
2.7% |
Drug Rash With Eosinophilia And Systemic Symptoms |
2.7% |
Epistaxis |
2.7% |
|
Secondary |
Drug Use For Unknown Indication |
36.0% |
Urinary Tract Infection |
15.5% |
Product Used For Unknown Indication |
10.1% |
Osteoporosis |
8.6% |
Drug Exposure During Pregnancy |
6.5% |
Prostatitis |
4.7% |
Cystitis |
3.6% |
Arthralgia |
1.8% |
Constipation |
1.8% |
Infection |
1.4% |
Klebsiella Infection |
1.4% |
Antibiotic Prophylaxis |
1.1% |
Dysuria |
1.1% |
Incontinence |
1.1% |
Palpitations |
1.1% |
Pulmonary Embolism |
1.1% |
Tachycardia |
1.1% |
Chronic Lymphocytic Leukaemia |
0.7% |
Escherichia Infection |
0.7% |
Essential Hypertension |
0.7% |
|
Pruritus |
17.6% |
Pulmonary Fibrosis |
10.8% |
Thrombocytopenia |
10.8% |
Jaundice |
6.8% |
Hepatic Fibrosis |
5.4% |
Fall |
4.1% |
Inflammation |
4.1% |
Rash Maculo-papular |
4.1% |
Somnolence |
4.1% |
Tachycardia |
4.1% |
Tremor |
4.1% |
Colitis Microscopic |
2.7% |
Drug Hypersensitivity |
2.7% |
Haematoma |
2.7% |
Interstitial Lung Disease |
2.7% |
Metrorrhagia |
2.7% |
Respiratory Failure |
2.7% |
Tendon Pain |
2.7% |
Toxic Skin Eruption |
2.7% |
Vitamin B12 Increased |
2.7% |
|
Concomitant |
Drug Use For Unknown Indication |
22.0% |
Product Used For Unknown Indication |
12.7% |
Hypertension |
8.0% |
Prophylaxis |
8.0% |
Urinary Tract Infection |
6.1% |
Rheumatoid Arthritis |
4.4% |
Nausea |
3.8% |
Restless Legs Syndrome |
3.7% |
Odynophagia |
3.5% |
Pain |
3.1% |
Bronchitis |
3.0% |
Micturition Urgency |
3.0% |
Dyspepsia |
2.6% |
Pyrexia |
2.6% |
Thrombosis Prophylaxis |
2.6% |
Diarrhoea |
2.4% |
Stomatitis |
2.4% |
Prophylaxis Of Nausea And Vomiting |
2.1% |
Anaemia |
1.9% |
Dehydration |
1.9% |
|
Urinary Tract Infection |
12.7% |
Pancreatitis |
7.9% |
Vomiting |
7.9% |
Confusional State |
6.3% |
Nausea |
6.3% |
Psychotic Disorder |
6.3% |
Urinary Retention |
6.3% |
Convulsion |
4.8% |
Pyelonephritis |
4.8% |
Thrombocytopenia |
4.8% |
Alcohol Poisoning |
3.2% |
Anaemia |
3.2% |
Fatigue |
3.2% |
Hypertension |
3.2% |
Injury Asphyxiation |
3.2% |
Lobar Pneumonia |
3.2% |
Premature Baby |
3.2% |
Premature Labour |
3.2% |
Pulmonary Embolism |
3.2% |
Sepsis |
3.2% |
|